Planning secondary prevention: Room for improvement.

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Background:

• Prognosis after acute coronary syndromes (ACS) remains suboptimal due to persistent risks of recurrent cardiovascular events.
• While significant progress has been made, further improvements in secondary prevention are necessary.

Purpose of the Study:

• To review current secondary prevention strategies for cardiovascular events post-ACS.
• To identify areas for improvement, including pharmacological and non-pharmacological interventions.
• To discuss the future direction of research towards a more patient-centered model.

Main Methods:

• Literature review of current secondary prevention strategies.
• Discussion of recent advances in antithrombotic and lipid-lowering therapies.
• Exploration of novel approaches for diabetic patients and anti-inflammatory treatments.
• Analysis of challenges in medication adherence and patient engagement.

Main Results:

• Pharmacological interventions (antithrombotics, lipid-lowering) have advanced but face challenges with cost and side effects.
• Non-pharmacological strategies, including patient communication and multidisciplinary care, are crucial.
• Identifying high-risk patients and personalizing treatment are priorities.
• Low medication adherence remains a significant barrier to effective secondary prevention.

Conclusions:

• Optimizing secondary prevention requires a blend of advanced pharmacological treatments and robust non-pharmacological interventions.
• A shift towards a patient-centered clinical and research model is advocated to improve long-term outcomes after ACS.
• Multidisciplinary team collaboration and cardiac rehabilitation are essential for comprehensive secondary prevention.